PLUR Bathi mangsa ngarep Pluri

Logo korporat perusahaan Pluri Inc. (PLUR)

The commercialization of placental cells and breakthroughs in the cultivated meat sector are driving the strategic direction of Pluri Inc. (PLUR). Forward-looking financial results reflect market expectations, where the latest parameter stands at . Scalable production enables premium pricing for its drugs, while innovative anti-inflammatory methods and the sustainability trend solidify the company's growth potential.

Pluristem Therapeutics (PLUR): Bathi mangsa ngarep saka 04.07.2022 nganti 16.11.2026

Rincian metrik keuangan lan pasar Pluristem Therapeutics (PLUR)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:Pluri, PLUR
Produk merek Pluri

Pluri Inc. is developing a capital-intensive 3D cell cultivation technology, where high patent margins offset the costs of bioreactors. A mathematical model converts these expectations into a cash equivalent by aggregating analytical forecasts. This indicator measures expected net profit, stripping fundamental value of market volatility. The trajectory of the projected profit level allows for an assessment of the current capitalization's fairness. Analysis of this chart cautions investors against purchasing the asset at the peak of a speculative trend.

Pesaing wigati

ASND (ascendispharma.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Madrigal Pharma|Bathi mangsa ngarep CORT (Corcept)|RYTM (Rhythm Corp) - Penghasilan resik sing dikarepake|Bathi sing dikarepake akerotx.com AKRO|MTSR - Bathi mangsa ngarep|MoonLake Corp - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Crinetics Pharma|NAMS (NewAmsterdam Pharma Company N.V.) - Bathi mangsa ngarep|SLNO: Bathi resik mangsa ngarep|FOLD (Amicus Corp) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep 89bio, Inc.|Proyeksi bathi mangsa ngarep AGIO|Bathi sing dikarepake GPCR (Structure Therapeutics Inc)|Bathi sing dikarepake mimedx.com MDXG|Rezolute Bio (RZLT) - Bathi resik sing dikarepake|LXRX - Bathi sing dikarepake|Prakiraan bathi perusahaan mbxbio.com MBX|Altimmune Inc (ALT) - Bathi sing dikarepake|AARD - Prakiraan bathi perusahaan|Bathi sing dikarepake Sagimet Biosciences Inc|BioAge Labs, Inc (BIOA) - Prakiraan bathi perusahaan|Bathi sing dikarepake biomeafusion.com (BMEA)|Bathi mangsa ngarep Quince Therapeutics Inc QNCX|Proyeksi bathi mangsa ngarep GUTS (Fractyl Health, Inc.)|vtvtherapeutics.com - Bathi sing dikarepake|agapeatpgroup.com - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Synlogic|Lipocine Corp (LPCN) - Bathi sing dikarepake|MTNB: Bathi resik mangsa ngarep|Bathi mangsa ngarep SPRB|Bathi resik sing dikarepake Galecto GLTO|Proyeksi bathi mangsa ngarep CTCX|Prakiraan bathi perusahaan Lumos Pharma, Inc.|Bathi sing dikarepake Organovo Holdings ONVO|Prakiraan bathi perusahaan Radius Recycling (RDUS)